Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy
Despite advances in its treatment, heart failure remains a major cause of morbidity and mortality, evidencing an urgent need for novel mechanism-based targets and strategies. Myocardial hypertrophy, caused by a wide variety of chronic stress stimuli, represents an independent risk factor for the dev...
Main Authors: | David Aluja, Sara Delgado-Tomás, Marisol Ruiz-Meana, José A. Barrabés, Javier Inserte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/8/4103 |
Similar Items
-
Spatio-temporal regulation of calpain activity after experimental myocardial infarction in vivo
by: Kun Zhang, et al.
Published: (2021-12-01) -
Variability of μ-Calpain and Calpastatin genes in cattle
by: Claudio Lisa, et al.
Published: (2010-01-01) -
Calpain Regulation and Dysregulation—Its Effects on the Intercalated Disk
by: Micah W. Yoder, et al.
Published: (2023-07-01) -
Distinct Changes in Calpain and Calpastatin during PNS Myelination and Demyelination in Rodent Models
by: John A. Miller, et al.
Published: (2022-12-01) -
Identification of Calpain Substrates by ORF Phage Display
by: Wei Li, et al.
Published: (2011-02-01)